Chen Y, Morimoto S, Kitano S, Koh E, Fukuo K, Jiang B, Chen S, Yasuda O, Hirotani A, Ogihara T
Department of Geriatric Medicine, Osaka University Medical School, Japan.
Atherosclerosis. 1995 Jan 6;112(1):69-76. doi: 10.1016/0021-9150(94)05400-d.
The effects of lysophosphatidylcholine (LPC), a vasoactive phospholipid, on intracellular free calcium concentration ([Ca2+]i), DNA synthesis and cytotoxicity of vascular smooth muscle cells (VSMC) were studied. LPC from 10(-7) to 10(-5) mol/l dose-dependently induced a sustained increase in [Ca2+]i. In contrast to the response of [Ca2+]i induced by angiotensin II, that induced by LPC was totally abolished when extracellular Ca2+ was removed, was not affected by pretreatment of the cells with islet-activating protein, and was not desensitized by repeated addition. 8-(N,N-Diethylamino)octyl 3,4,5-trimethoxybenzoic acid (TMB-8), an inhibitor of Ca2+ release from intracellular Ca2+ stores, 1-(5-isoquinolinesulfonyl)-2-methylpiperadine dihydrochloride (H-7), an inhibitor of protein kinase C, KT5823, an inhibitor of protein kinase G, and Ca2+ channel blockers failed to suppress the LPC-induced increase in [Ca2+]i. LPC at 10(-5) mol/l caused significant stimulation of [3H]thymidine incorporation into VSMC, and at concentrations of 10(-5) mol/l and higher dose-dependently stimulated release of lactate dehydrogenase in cell culture supernatants. Moreover, digitonin mimicked the effects of LPC on [Ca2+]i, and also caused similar effects to those of LPC on DNA synthesis and cytotoxicity in VSMC. These observations suggest that LPC causes both cell growth and cell injury of VSMC, at least partly, through its detergent action, causing membrane leakiness and resultant [Ca2+]i overload in vitro, thus indicating the possible participation of LPC in atherosclerosis and/or injury of the vascular wall.
研究了血管活性磷脂溶血磷脂酰胆碱(LPC)对血管平滑肌细胞(VSMC)细胞内游离钙浓度([Ca2+]i)、DNA合成及细胞毒性的影响。10(-7)至10(-5)mol/L剂量依赖性的LPC可诱导[Ca2+]i持续升高。与血管紧张素II诱导的[Ca2+]i反应不同,去除细胞外Ca2+时,LPC诱导的反应完全消失,细胞用胰岛激活蛋白预处理对此无影响,且反复添加不会使其脱敏。8-(N,N-二乙氨基)辛基3,4,5-三甲氧基苯甲酸(TMB-8),一种细胞内Ca2+储存释放Ca2+的抑制剂,1-(5-异喹啉磺酰基)-2-甲基哌啶二盐酸盐(H-7),一种蛋白激酶C的抑制剂,KT5823,一种蛋白激酶G的抑制剂,以及Ca2+通道阻滞剂均未能抑制LPC诱导的[Ca2+]i升高。10(-5)mol/L的LPC可显著刺激VSMC中[3H]胸苷掺入,且在10(-5)mol/L及更高浓度时剂量依赖性地刺激细胞培养上清液中乳酸脱氢酶的释放。此外,洋地黄皂苷模拟了LPC对[Ca2+]i的影响,并且在VSMC中对DNA合成和细胞毒性也产生了与LPC类似的作用。这些观察结果表明,LPC至少部分地通过其去污剂作用导致VSMC的细胞生长和细胞损伤,在体外引起膜渗漏并导致[Ca2+]i过载,从而表明LPC可能参与动脉粥样硬化和/或血管壁损伤。